Latest News
The effects of infection don't necessarily end when the first symptoms subside. The new center will work to unravel the mysteries of lingering diseases.
- September 08, 2023Source: Yale Daily News
Yale researchers, led by Professor Mark Saltzman, have successfully created an mRNA no-shot COVID vaccine, which successfully protects against COVID-19 in mice.
- August 25, 2023
Yale scientists are evaluating a new method to treat debilitating and deadly pulmonary fibrosis.
- July 31, 2023Source: McKnight Foundation
The McKnight Endowment Fund for Neuroscience has selected Junjie Guo, PhD, from Yale Neuroscience, to receive the 2023 Neurobiology of Brain Disorders Awards. This award supports innovative research by U.S. scientists who are studying the biological mechanisms of neurological and psychiatric disorder.
- July 27, 2023Source: YaleNews
In a promising form of immunotherapy known as CAR T-cell (chimeric antigen receptor) therapy, the patient’s T cells are engineered to better recognize and attack antigens on the surface of cancer cells.
- July 25, 2023
The Yale Center for RNA Science and Medicine members came together last Thursday for a delightful and enriching Midsummer's RNA Dreams happy hour at the beautiful Rose Garden at the School of Medicine.
- July 25, 2023Source: Stamford Advocate
A group of Yale researchers is working on a new kind of vaccine they believe could change the world: instead of acting against a pathogen, the vaccine would reduce the risk of transmission for mosquito-and-tick-borne illnesses by targeting the insects themselves.
- July 18, 2023Source: Technology Networks
As more is learned about how stem cell populations affect health, the ability to manipulate those populations will become more important in healthcare.
- July 17, 2023Source: YaleNews
Researchers at Yale School of Medicine have found that levels of diversity of blood stem cells are determined during the development of the embryo.
- July 10, 2023Source: Yale West Campus
Scientists at Yale have developed a new gene delivery and immune cell engineering technology with the potential to advance cell therapies for cancer and other diseases.